more information about ULTOMIRIS, please refer to the package insert. In case of safety concerns, please contact. PatientSafety.SG
Soliris [package insert]. Boston, MA: Alexion Pharmaceuticals, Inc.: 7/2024. 2. Ultomiris [package insert]. Boston, MA: Alexion Pharmaceuticals, Inc
Ultomiris is not indicated for the treatment of patients with Shiga toxin E. Soliris [package insert]. Boston, MA: Alexion Pharmaceuticals, Inc.; June
Read these materials ahead of prescribing ULTOMIRIS to your patients. Please see the Singapore Package Insert (PI) for ULTOMIRIS, including information
2. Ultomiris [package insert]. Boston, MA: Alexion Pharmaceuticals, Inc.: 10/2024. 3. Uplizna [package insert]
Ultomiris [package insert]. Boston, MA: Alexion Pharmaceuticals, Inc, 2024. 2. Kaplan BS, Ruebner RL, Spinale JM, Copelovitch L. Current
Ultomiris (ravulizumab-cwvz) package insert. Cheshire, CT; Alexion. Pharmaceuticals, Inc.; April 2024. 7. Parker C, Omine M, Richards S, et al. Diagnosis
Soliris [package insert]. Boston, MA: Alexion Pharmaceuticals, Inc. November 2024. 2. Ultomiris [package insert]. Boston, MA: Alexion
Soliris (eculizumab) [package insert]. Boston, MA: Alexion Pharmaceuticals, Inc.; November 2024. Ultomiris (ravulizumab-cwvz) [package insert]
I would like to know more about this package. ^.^